In summary, we provided evidence that MSI-N1014 suppressed the major colon cancer stemness markers, LGR5 and β-catenin, and oncogenic signaling, such as mTOR and IL-6; it also prevented cancer cell-mediated CAF transformation. Here, LGR5 is linked to malignant colon neoplasm.